What's breaking now, across thousands of outlets.
MUNICH — Cytokinetics’ heart drug Myqorzo could gain expanded approval next year, potentially doubling its market reach, after detailed results backed the drug’s use in a heart muscle disease. The new data, presented at the European ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
More than 50,000 doses of the Ervebo vaccine have been received, according to Congo's state news agency
More than 50,000 doses of the Ervebo vaccine have been received, according to Congo's state news agency
Das Mittel Wegovy gibt es nun auch als Tablette in der EU – zuerst in Deutschland. Das Konkurrenzprodukt von Eli Lilly gibt es bisher noch nicht.
KUALA LUMPUR: Kelantan Red Warrior could be without up to 11 players for Saturday’s Super League match against Kuching City after an influenza outbreak hit the squad.
